Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nanoporous microsystems for islet cell replacement.

Tejal A Desai1, Teri West, Michael Cohen

  • 1Department of Biomedical Engineering, Boston University, 44 Cummington Street, Boston, MA 02215 USA. tdesai@bu.edu

Advanced Drug Delivery Reviews
|September 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PARP7 inhibitors enhance the immunogenic effects of radiation in pancreatic cancer cells.

Molecular therapy. Oncology·2026
Same author

A Mass Cytometry-Based Blood Cell Phenotyping Workflow Enabling Inclusion of Resource-Limited and Rural Sites in Immune System Studies.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2026
Same author

Towards intelligent and miniaturized drug delivery devices.

Nature·2026
Same author

Mass Cytometry Workflow to Achieve High-Dimensional Immunophenotyping in Resource-Limited or Decentralized Environments.

Current protocols·2026
Same author

Mitochondrial Permeability Transition in Skeletal Muscle Phenocopies Muscle Alterations seen in Cancer Cachexia and other Wasting Conditions.

bioRxiv : the preprint server for biology·2026
Same author

Applications and challenges of utilizing digital pathology and AI-enabled workflows in clinical trials.

Journal of pathology informatics·2026

New nanoporous biocapsules offer a promising alternative for islet cell transplantation in type 1 diabetes, potentially overcoming immune rejection and improving glucose control.

Area of Science:

  • Biotechnology
  • Materials Science
  • Endocrinology

Background:

  • Conventional insulin therapy for type 1 diabetes is often inadequate.
  • Islet cell transplantation is a physiological alternative but faces immune rejection challenges.
  • Existing encapsulation technologies have limitations like material instability and broad pore sizes.

Purpose of the Study:

  • To develop novel immunoisolating microenvironments for cellular delivery.
  • To overcome limitations of current islet cell transplantation and encapsulation methods.
  • To explore micro- and nanotechnology for improved therapeutic alternatives.

Main Methods:

  • Utilizing bulk and surface micromachining to create nanoporous biocapsules.
  • Engineering uniform pore sizes as small as 7 nm.

Related Experiment Videos

  • Tailoring surface chemistries and microarchitectures for precise cellular encapsulation.

    • Main Results:

    • Development of biocapsules with controlled pore sizes and tailored surface chemistries.
    • Creation of precise microarchitectures for immunoisolation.
    • Potential to overcome limitations of conventional encapsulation technologies.

    Conclusions:

    • Nanoporous biocapsules represent a novel approach for islet cell delivery.
    • This technology may provide effective immunoisolation, reducing graft rejection.
    • The approach holds promise for restoring normoglycemia in type 1 diabetes patients.